What Is Laurus Labs’s Net Debt? You can click the graphic below for the historical numbers, but it shows that as of March 2019 Laurus Labs had ₹10.4b of debt, an increase on ₹9.80b, over one year. Net debt is about the same, since the it doesn’t have much cash.
Similarly, Is Laurus Labs a good buy Quora?
Laurus Labs Ltd. is a Pharma Company. Due to Covid Wave, all pharma company stock has seen tremendous growth in their share price. Laurus Labs is also one of the stocks to see such growth and further growth is also expected from it. So one can conclude to buy Laurus Labs Share.
Why did Laurus Labs share fall? Laurus Labs was down on profit booking after the company reported a robust set of July-September quarter (Q2FY21) numbers. The company’s profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore for the quarter on the back of strong operational performance.
Thereof, Can I buy Laurus Labs?
Edelweiss has buy call on Laurus Labs with a target price of Rs 590. The current market price of Laurus Labs Ltd. is Rs 549.85. Time period given by analyst is Intra Day when Laurus Labs Ltd. price can reach defined target.
What is the future of Laurus?
Laurus Labs Ltd. quote is equal to 590.700 INR at 2022-03-29. Based on our forecasts, a long-term increase is expected, the « Laurus Labs Ltd » stock price prognosis for 2027-03-19 is 953.782 INR. With a 5-year investment, the revenue is expected to be around +61.47%.
Why is Laurus Labs going down?
Laurus Labs was down on profit booking after the company reported a robust set of July-September quarter (Q2FY21) numbers. The company’s profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore for the quarter on the back of strong operational performance.
What is the intrinsic value of Laurus Labs?
Laurus Labs
| As Of | Intrinsic Value | Market Price |
|---|---|---|
| 31 Dec 2021 | Rs. 273.02 | Rs. 538.90 |
| 8 Apr 2022 | —- | Rs. 605.10 |
| 5.95 0.98% |
Why Laurus Labs share is increasing?
However, Laurus Labs in Q3 results conference call said the company is witnessing increased demand for the ARV business. “Increased demand for ARV business, witnessing commodity customers and formation sales from global multilateral agencies comes from January-March quarter (Q4) onwards.
Why Laurus Labs share is rising?
Since February 10, 2022, the stock has rallied 12 per cent after the company said it received purchase orders from a leading global life sciences company and the supplies will commence from March 2022. The executions of these orders are subject to fulfillment of certain performance obligations.
Which share buy now?
Stocks to Buy Today: Best Shares to Buy in India
| Name | LTP | Chg.(%) |
|---|---|---|
| Axis Bank | 793.05 | -0.68 |
| B P C L | 379.00 | -0.42 |
| Bajaj Auto | 3,697.30 | -0.40 |
| Bajaj Finance | 7,328.45 | 0.74 |
What Laurus Labs do?
Laurus Labs is a leading research and development (‘R&D’) driven pharmaceutical company in India with a leadership position in generic active pharmaceutical ingredients (‘APIs’) for select high-growth therapeutic areas of anti-retrovirals (‘ARVs’) Hepatitis C and Oncology.
Is Laurus Labs undervalued?
So, clearly looking at PE ratio and PEG ratio, Laurus Labs is looking undervalued. Laurus Labs has a solid management and product portfolio a strong competitive advantage and they already have a solid future growth plan in place, it means earnings would increase at a good rate.
What is the intrinsic value of Divis Lab?
Divis Laboratories
| As Of | Intrinsic Value | Market Price |
|---|---|---|
| 31 Dec 2021 | Rs. 1,962.96 | Rs. 4,678.20 |
| 8 Apr 2022 | —- | Rs. 4,505.95 |
| 57.50 1.28% |
What is intrinsic value of Deepak Nitrite?
Deepak Nitrite
| As Of | Intrinsic Value | Market Price |
|---|---|---|
| 31 Dec 2021 | Rs. 1,029.44 | Rs. 2,490.20 |
| 7 Apr 2022 | —- | Rs. 2,326.05 |
| -3.30 -0.14% |
What is the target of Laurus lab?
Edelweiss has buy call on Laurus Labs with a target price of Rs 590. The current market price of Laurus Labs Ltd. is Rs 549.85.
Which stock will go up tomorrow?
stocks to buy tomorrow intraday NSE. Stocks going UP tomorrow
| Company | Today’s Movement | Tomorrow’s Movement |
|---|---|---|
| Vipul VIPULLTD Experts View | Bullish | might go UP Tomorrow buy |
| Visesh Infotecnics VISESHINFO Experts View | Bullish | might go UP Tomorrow buy |
| Wonderla Holidays WONDERLA Experts View | Bullish | might go UP Tomorrow buy |
Which share will grow in future?
growth stocks for future
| S.No. | Name | Qtr Profit Var % |
|---|---|---|
| 1. | Krsnaa Diagnost. | 331.83 |
| 2. | Bhansali Engg. | -44.40 |
| 3. | Supreme Petroch. | -4.13 |
| 4. | IOL Chemicals | -65.10 |
Which share is lowest price?
low price shares
| S.No. | Name | B.V. Rs. |
|---|---|---|
| 1. | Taparia Tools | 776.20 |
| 2. | B & A | 359.45 |
| 3. | I O C L | 136.23 |
| 4. | Keynote Finan. | 137.21 |
What is the intrinsic value of Irctc?
Indian Railway Catering and Tourism Corp
| As Of | Intrinsic Value | Market Price |
|---|---|---|
| 31 Dec 2021 | Rs. 28.45 | Rs. 831.75 |
| 11 Apr 2022 | —- | Rs. 801.40 |
| 11.05 1.38% |
What is the business model of Divis Lab?
Divi’s Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies.
What do Divis Lab do?
Divis Laboratories, established in 1990, manufactures Active Pharma Ingredients (APIs) and intermediates. Divis Laboratories focuses on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
What is the intrinsic value of Sun Pharma?
Sun Pharmaceuticals
| As Of | Intrinsic Value | Market Price |
|---|---|---|
| 31 Dec 2021 | Rs. 491.30 | Rs. 845.70 |
| 6 Apr 2022 | —- | Rs. 928.10 |
| -1.00 -0.11% |
Join TheMoney.co community and don’t forget to share this post !
